Cargando…
Identification of Moesin (MSN) as a Potential Therapeutic Target for Colorectal Cancer via the β-Catenin-RUNX2 Axis
CRC is the second leading cause of cancer-related death. The complex mechanisms of metastatic CRC limit available therapeutic choice. Thus, identifying new CRC therapeutic targets is essential. Moesin (MSN), a member of the ezrin–radixin–moesin family, connects the cell membrane to the actin-based c...
Autores principales: | Huang, Chien-Yu, Wei, Po-Li, Batzorig, Uyanga, Makondi, Precious Takondwa, Lee, Cheng-Chin, Chang, Yu-Jia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341927/ https://www.ncbi.nlm.nih.gov/pubmed/37446127 http://dx.doi.org/10.3390/ijms241310951 |
Ejemplares similares
-
Human α-defensin 6 (HD6) suppresses CRC proliferation and metastasis through abolished EGF/EGFR signaling pathway
por: Wei, Po-Li, et al.
Publicado: (2022) -
Development of novel predictive miRNA/target gene pathways for colorectal cancer distance metastasis to the liver using a bioinformatic approach
por: Makondi, Precious Takondwa, et al.
Publicado: (2019) -
Prediction of novel target genes and pathways involved in irinotecan-resistant colorectal cancer
por: Makondi, Precious Takondwa, et al.
Publicado: (2017) -
Prediction of novel target genes and pathways involved in bevacizumab-resistant colorectal cancer
por: Makondi, Precious Takondwa, et al.
Publicado: (2018) -
Bromelain inhibits the ability of colorectal cancer cells to proliferate via activation of ROS production and autophagy
por: Chang, Tung-Cheng, et al.
Publicado: (2019)